Next, by searching in miRWalk database, we found that FGF‐21, a central regulator for lipid metabolism, is a previously validated target gene of miR‐212, while no validated target gene of miR‐205 has been found to be involved in NAFLD. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.